foxo4 dri senolytic human trials FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Frontiers | FOXO4-DRI regulates endothelial

Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: a randomized dose-ranging study

Homocysteine and methylmalonic acid levels in the blood are stronger indicators of proper vitamin B12 activity than homocysteine

Neurological and Cognitive Benefits Protects neurons from oxidative and ischemic injury

Unlike most regulatory peptides, the molecule resists gastric proteolysis intact a feature that has driven much of the oral-administration preclinical work and that distinguishes it from injectable-only fragments such as TB-500

Resveratrol (RSV) has been shown to be effective at removing excess reactive oxygen species (ROS) or reactive nitrogen species generation in the central nervous system (CNS), but the delivery of RSV into the brain through systemic administration is inefficient

No trials specifically enrolled elderly individuals, those with significant cardiovascular disease, individuals with active cancer, or pregnant/breastfeeding women